Which inhaled corticosteroid is specifically indicated for Asthma management?

Mometasone is an inhaled corticosteroid that is specifically indicated for the management of asthma. It acts by reducing inflammation in the airways, which is a key factor in asthma management. Corticosteroids like mometasone help to decrease airway hyperresponsiveness, swelling, and mucus production, leading to improved airflow and fewer asthma symptoms.

This medication is often used as part of a long-term asthma management plan, providing patients with better control over their condition. Regular use of inhaled corticosteroids has been shown to decrease the frequency and severity of asthma attacks, making them an essential element in asthma treatment protocols.

The other options are not indicated for the management of asthma in the same manner. Montelukast, although it is used in asthma treatment, is not an inhaled corticosteroid; it functions as a leukotriene receptor antagonist. Albuterol is a short-acting beta-agonist used for quick relief of asthma symptoms but does not have the anti-inflammatory properties of inhaled corticosteroids. Ciclesonide is another inhaled corticosteroid similar to mometasone and is also used for asthma management, but in this context, mometasone is the more established choice.